US Bioservices Announces Record Breaking Year for New Business Wins in Rare & Orphan, Oncology and Specialty Infusion
February 7, 2018
“Patients struggling with cancer and managing rare diseases require very specialized, clinically-coordinated care and service. We understand the critical expertise and commitment required to deliver solutions and support to patients who benefit from specialized therapies,” said Kelly Ratliff, President of US Bioservices. “We were built, over 25 years, on providing high-acuity pharmacy and nursing support. Because we began as a home infusion pharmacy – providing infusion and nursing services to patients upon discharge from an acute care setting – we have a unique understanding of, and appreciation for, the level of care our patients need and deserve. We continue to align our investment and innovation strategies to ensure that we remain a premier partner in support of oncology and rare disease patient populations.”
US Bioservices’ portfolio offers broad access to oncology, rare and orphan and specialty infusion products to support a wide variety of providers and patients.
Specialty Infusion: US Bioservices has more than 25 years of experience providing specialty infusion therapies, including IV drugs, and self-administered infusion and injection medications, to patients nationwide. US Bioservices offers personalized clinical support, including self-infusion training, in-home infusion nursing services and 24/7 access to clinical support.
Oncology: As a specialty pharmacy, US Bioservices understands its unique position as a member of the care team that supports cancer patients holistically. With more than 80 members, US Bioservices’ dedicated Oncology Patient Support Team provides high-touch clinical care that is specific to the patient’s needs, conditions and therapies. The pharmacy’s multidisciplinary teams and field-based Oncology Account Executives and Clinical Practice Consultants are organized to develop long-standing, collaborative relationships with oncologists, resulting in more integrated care for patients and caregivers.
Rare & Orphan: US Bioservices is committed to helping small patient populations navigate the hurdles in accessing their therapies and maintaining its benefits. Each patient and caregiver has a unique set of needs that require customized, high-touch solutions that improve adherence and outcomes. US Bioservices’ depth of experience supporting rare and orphan programs combined with AmerisourceBergen’s Signature® commercialization solutions provide a range of program and partnership options that can be optimized and tailored to maximize results.
Through comprehensive technology systems, US Bioservices’ manufacturer partners get a transparent view into the therapy experience. Timely and actionable data allows manufacturers gain insights to increase support for providers and patients throughout the therapeutic journey.
US Bioservices leverages the breadth and depth of resources provided by AmerisourceBergen companies, including Lash Group for patient support services; ION Solutions and Oncology Support for their connections to community oncology providers and ICS and ASD Healthcare for rare and orphan logistics and distribution expertise. US Bioservices supports AmerisourceBergen customers’ access to specialty products that are critical to improving outcomes and the patient experience across the continuum of care, from oncology practices to health system specialty pharmacies and community pharmacies. For more information about US Bioservices, please visit: www.usbioservices.com.
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 20,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $150 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.
About US Bioservices
US Bioservices, a part of AmerisourceBergen, delivers nationwide specialty pharmacy and nursing services that meet the unique needs of patients, physicians, payers, and manufacturers. US Bioservices’ approach combines superior patient-centric customer service, clinical expertise, and robust data analytics. Their partner solutions, such as the MyPathpoint Portal, provide unmatched transparency and increased clinical collaboration that improves patient outcomes. For more information, visit www.usbioservices.com.